Showing results (171-180 of 284) with videos related to
Sort By:
Pageof 29
Biorxiv : the Preprint Server for Biology|April 17, 2026
PBP1A and LdtJ support cell envelope homeostasis and impact selection of Colistin-resistance in Acinetobacter baumanniiBerenice Furlan, Sinjini Nandy, Hanling Gong, et al.International Journal of Oncology|February 15, 2001
Immunotherapy (recombinant interleukin 2), hormone therapy (medroxyprogesterone acetate) and antioxidant agents as combined maintenance treatment of responders to previous chemotherapyG Mantovani, A Maccio, C Madeddu, et al.European Journal of Haematology|February 14, 2004
Salvage therapy with an outpatient DHAP schedule followed by PBSC transplantation in 79 lymphoma patients: an intention to mobilize and transplant analysisAttilio Olivieri, Marino Brunori, Debora Capelli, et al.Antibiotics (Basel, Switzerland)|February 26, 2025
A Precision Medicine Model for Targeted Antibiotic Therapy in Urinary Tract Infections: A Valuable Tool to Reduce Hospitalization Stay and the Time to Switch to Oral TreatmentTommaso Cai, Anna Brugnolli, Massimiliano Lanzafame, et al.Medicina (Kaunas, Lithuania)|October 28, 2023
Harnessing Minimal Residual Disease as a Predictor for Colorectal Cancer: Promising Horizons Amidst ChallengesXiaofen Wen, Donatella Coradduzza, Jiaxin Shen, et al.Journal of Translational Medicine|September 26, 2014
ERCC1 polymorphisms as prognostic markers in T4 breast cancer patients treated with platinum-based chemotherapyGrazia Palomba, Francesco Atzori, Mario Budroni, et al.BMC Cancer|August 26, 2010
Molecular alterations in key-regulator genes among patients with T4 breast carcinomaBruno Massidda, Mariacristina Sini, Mario Budroni, et al.Journal of Chemotherapy (Florence, Italy)|June 12, 2003
Randomized, controlled, multicenter phase III trial of standard-dose fluorouracil-epirubicin-cyclophosphamide (FEC), compared with time-intensive FEC (FEC-G) and mitoxantrone-methotrexate-mitomycin C (MMM-G) in metastatic breast carcinomaA M Capotorto, L Pavesi, P Pedrazzoli, et al.British Journal of Haematology|September 6, 2000
Amifostine can reduce mucosal damage after high-dose melphalan conditioning for peripheral blood progenitor cellautotransplant: a retrospective studyD Capelli, G Santini, C De Souza, et al.Bone Marrow Transplantation|September 12, 2001
Very low toxicity and good quality of life in 48 elderly patients autotransplanted for hematological malignancies: a single center experienceA Olivieri, D Capelli, M Montanari, et al.Pageof 29